Can persistent exposure to Aspergillus or indoor molds drive chronic rhinitis or asthma-type inflammation?

Persistent exposure to Aspergillus and other indoor molds is a clinically recognized driver of chronic respiratory inflammation, manifesting as both chronic rhinitis and asthma-type pathology. Research confirms that these conditions are maintained through complex interactions between the adaptive and innate immune systems.

Clinical evidence

The association between mold sensitization and respiratory disease is robust. Sensitization to Aspergillus is a powerful predictor of asthma severity, with studies showing an odds ratio (OR) of 2.36 for severe asthma in sensitized individuals. In pediatric populations, every doubling of specific IgE (sIgE) to Aspergillus is associated with a 1.55-fold increase in the odds of current asthma. Furthermore, living in damp or mold-damaged environments is strongly linked to chronic rhinitis and persistent nasal symptoms, regardless of whether a patient has a history of atopy.

Mechanistic pathways

The inflammatory response to mold occurs through two primary, often overlapping pathways:

• IgE-mediated responses: Traditional allergic sensitization involves the production of sIgE antibodies. This adaptive response triggers Type I hypersensitivity, leading to classic allergic rhinitis and asthma symptoms upon re-exposure.
• Non-IgE-mediated responses: Mold can drive inflammation independently of IgE via innate immune activation. Aspergillus fumigatus secretes serine proteases (such as Asp f13) that directly degrade airway epithelial barriers. These fragments also activate Toll-like receptor 2 (TLR2), prompting bronchial cells to release pro-inflammatory cytokines like IL-6 and IL-8. Additionally, mold-induced damage triggers "alarmins" (e.g., IL-33), which activate Group 2 innate lymphoid cells (ILC2s). These cells produce IL-5 and IL-13, sustaining eosinophilic inflammation and mucus hypersecretion without requiring IgE or T-cell involvement.

Bottom line

Chronic exposure to indoor mold drives respiratory inflammation through a dual-mechanism process. While IgE-mediated allergy is common, non-IgE-mediated innate pathways—including direct protease damage and ILC2 activation—ensure that inflammation persists even in the absence of traditional allergic markers.